TABLE 1.
Strain | Relevant genotype | Source or Ref. |
---|---|---|
E. coli DH5α | recA1;endA1;gyrA96; thi;relA1;hsdR17 (rK−;mK+); supE44; f80ΔlacZΔM15;DlacZYA-argF; UE169 | Novagen |
E. coli BL21(DE3) | fhuA2[lon]ompT gal (λDE3)[dcm]ΔhsdSλDE3 | Novagen |
M. smegmatis mc2155 | Wild-type (WT) M. smegmatis strain | 52 |
MtbH37Rv | Wild-type (WT) M. tuberculosis strain | ATCC 25618 |
ΔphoPMtb H37Rv | ΔphoP::attP-kan-attP | Smith and co-workers (27) |
Complemented ΔphoPMtb H37Rv | ΔphoP::pSM607 | Smith and co-workers (27) |
Plasmids | ||
pET-15ba | E. coli cloning vector | Novagen |
pET-phoP | His6-tagged PhoP expression plasmid | 58 |
pET-espR | His6-tagged EspR expression plasmid | This study |
pET-28cb | E. coli cloning vector | Novagen |
pET-crp | His6-tagged CRP expression plasmid | This study |
p19Kproc | Mycobacteria expression vector | 56 |
p19Kpro-espACD | Entire 1–3233 bp espACD operon cloned in p19Kpro | This study |
p19Kpro-espB | EspB residues 1–460 cloned in p19Kpro | This study |
p19Kpro-espR | EspR residues 1–132 cloned in p19Kpro | This study |
p19Kpro-phoP | PhoP residues 1–247 cloned in p19Kpro | This study |
pME1mL0031b | Mycobacterial protein expression vector | 61 |
pME1mL1-phoP | PhoP residues 1–247 cloned in pME1mL1 | This work |
pSM128d | Integrative promoter probe vector for mycobacteria | 57 |
pSM-espAup | espAup-lacZ fusion in pSM128 | This work |
pSM-espAupmut | Mutant espAup-lacZ fusion carrying changes in the PhoP-binding site | This work |
pRSF-Duet-1b | E. coli cloning vector | Novagen |
pRSF-Duet-phoP-espR | S-tagged PhoP and His-tagged EspR expression plasmid | This study |
pUAB400 b | Integrative mycobacteria, E. coli shuttle plasmid | 48 |
pUAB400-phoP | PhoP residues 1–247 cloned in pUAB400 | 55 |
pUAB300c | Episomal mycobacteria, E. coli shuttle plasmid | 48 |
pUAB300-espR | EspR residues 1–132 cloned in pUAB300 | This study |
pUAB300-phoR | PhoR residues 1–485 cloned in pUAB300 | 55 |
a Ampr is ampicillin resistance.
b Kanr is kanamycin resistance.
c Hygr is hygromycin resistance.